« Previous
Next »
Respiratory Medicine
Volume 102, Issue 12
, Pages 1708-1714
, December 2008
Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions
References
- . Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–513
- . Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med. 1973;132:854–860
- . State of the art: the pleura. Am Rev Respir Dis. 1988;138:184–234
- . Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc. 1985;60:158–164
- . Diagnostic reliability of needle biopsy of the parietal pleura: a review of 272 biopsies. Am J Clin Pathol. 1979;72:48–51
- . Pleural biopsy and thoracoscopy. Eur Respir Mon. 1998;9:135–152
- . Sensitivity, specificity and predictive values of closed pleural biopsy. Arch Intern Med. 1984;144:325–328
- . Computed tomography of localized pleural mesothelioma. Am J Roentgenol. 1985;144:275–280
- . CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol. 1990;154:487–492
- . Malignant pleural effusions. In: Fischman AP editors. Pulmonary diseases and disorders. 2nd ed. New York: Mc Graw-Hill; 1988;p. 2159–2170
- Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest. 2002;122(6):1918–1924
- Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F-FDG PET. Radiology. 2004;231(3):858–865
- Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest. 2004;125(2):489–493
- 18F-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun. 2006;27:971–976
- Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol. 1993;151:7216–7223
- . Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep. 2000;7:1327–1332
- Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration. 1998;65:183–186
- . Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest. 1991;99:1103–1107
- . Soluble interleukine-6 receptor levels in pleural effusions. Respir Med. 1996;90:329–332
- . Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor-α in the differentiation of exudates and transudates in pleural effusions. Anticancer Res. 1999;19:3607–3612
- Diagnostic value of interleukin-1α, interleukin-6, and tumor necrosis factor in pleural effusions. Chest. 2002;121:815–820
- . Anti-inflammatory cytokines. Chest. 2000;117:1162–1172
- . Cytokines: l. overview. Thorax. 1993;48:660–667
- . Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest. 1990;97:1439–1445
- . Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline. Am Rev Respir Dis. 1993;147:1503–1506
- . Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987;105:1039–1045
- A possible role of TGF-β in the formation of malignant effusions. Clin Immunol Immunopathol. 1995;77:27–32
- Transforming growth factor-beta 1 (TGF-β1)- and β2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol. 1994;98:319–322
- . Cytokines and soluble cytokine receptors in pleural effusions from septic and non septic patients. Am J Respir Crit Care Med. 1997;156:1515–1522
- . Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331:1286–1292
- . Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax. 1999;54:707–710
- . Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–985
- . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851–858
- Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J. 2005;25:600–604
- . Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med. 2002;8:294–301
- . Malignant pleural effusion: would the real cause please stand up?. Eur Respir J. 1997;10:1701–1702
- Vascular endothelial growth factor in pleural fluid. Chest. 1999;116:760–765
- . Vascular endothelial growth factor in malignant and tuberculous pleural effusions. J Korean Med Sci. 2000;15:279–283
- Vascular endothelial growth factor level correlates with transforming growth factor-β isoform levels in pleural effusions. Chest. 2000;118:1747–1753
- Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med. 2002;96:817–822
- Vascular endothelial growth factor in benign and malignant pleural effusions. Arch Bronconeumol. 2005;41:376–379
- Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J. 2007;30:957–964
- . CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis. 2005;63:17–22
- . Cytokines in pleural diseases. Chapter 6 In: Light RW, Lee YCG editor. Textbook of pleural disease. London: Arnold Publishers; 2003;p. 63–89
- Proinflammatory cytokines, transforming growth factor-β1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest. 2005;128:690–697
- The differential diagnostic values of cytokine levels in pleural effusions. Mediators Inflamm. 2005;2005(1):2–8
- Interleukin 6 activity in pleural effusion. Chest. 1992;102:1055–1059
PII: S0954-6111(08)00252-7
doi: 10.1016/j.rmed.2008.07.008
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
Respiratory Medicine
Volume 102, Issue 12
, Pages 1708-1714
, December 2008
